Company intelligence / Profile preview
Aeolian Biotech
Lincoln, Nebraska, United Statesaeolianbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Developing improved pneumococcal conjugate vaccine iPCV22 targeting 95% of serotypes causing invasive disease in US adults; no clinical results available yet.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Vaccine
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Aeolian Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aeolian Biotech.